Antiretroviral therapy during pregnancy and the risk of an adverse outcome

Most AIDS drugs do not increase the risk of premature birth, low birth weight, stillbirth, or low Apgar score in HIV-infected pregnant women, according to a study of 2,123 women. Women who took protease inhibitors had three times the risk of having a very-low-birth-weight baby. However, the risk was still low, occurring in 5% of women who took protease inhibitors and 2% of women who did not.